Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Beauveria
Promoting client goal ownership in a clinical setting
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.
Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder. JAMA. 2022 07 12; 328(2):213-214.
View in:
PubMed
subject areas
Administration, Sublingual
Antipsychotic Agents
Bipolar Disorder
Dexmedetomidine
Humans
Hypnotics and Sedatives
Psychomotor Agitation
authors with profiles
Bezalel Dantz